ArticleProceedings of the National Academy of Sciences of the United States of America2014

Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling.

Bhuvanesh Dave et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.